Quantitative Hormonal Biomarkers of Menstrual Health in Normal and Abnormal Cycles

What this Trial Is About

Researchers are evaluating hormonal patterns in menstrual cycles to better understand ovulation and fertility markers in women with regular cycles, polycystic ovarian syndrome (PCOS), and athletes. The study focuses on measuring four key reproductive hormones in urine and comparing them to blood hormone levels and ultrasound-confirmed ovulation. Additional clinical signs like menstrual bleeding, temperature changes, vital signs, and sleep patterns are also tracked to provide a comprehensive picture of menstrual health. Participants will use the Mira Monitor device to track menstrual hormones and biomarkers throughout their cycles. The study includes groups with regular cycles, PCOS with irregular cycles, and oligomenorrheic athletes. Regular ultrasounds will be performed to confirm ovulation, and hormone levels such as luteinizing hormone, progesterone, follicle-stimulating hormone, and estrogen will be measured over one year to predict and confirm ovulation and fertile windows. Participants will visit the clinic regularly for ultrasounds and hormone testing during the study period. They will provide urine samples and record clinical signs such as menstrual bleeding and temperature changes. Researchers will analyze correlations between hormone changes and menstrual cycle characteristics. The study will last one year, during which menstrual health and ovulation markers will be closely monitored and validated with ultrasound and serum hormone data.

Quantum Menstrual Health Monitoring Study